Navigation Links
Antares Pharma Announces Positive Results from Application Site,Study for Anturol

s, Minnesota and Basel, Switzerland.

Safe Harbor Statement

In addition to historical facts or statements or current conditions, this press release contains forward-looking statements within the meaning of the "Safe Harbor" provisions of The Private Securities Litigation Reform Act of 1995, including statements regarding the positive results. Forward-looking statements provide Antares' current expectation or forecasts of future events. Antares' results could differ materially from those reflected in these forward-looking statements due to decisions of regulatory authorities, Antares' ability to execute on its development plans and general financial, economic, regulatory and political conditions affecting the pharmaceutical industry generally. For a discussion of these and other risks and uncertainties that may effect the forward-looking statements, please see the risk factors in Antares' 10Q's, 10K's and other filings made with the Securities and Exchange Commission. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Antares undertakes no obligation to update publicly any forward-looking statement.

Contact

Antares Pharma, Inc.
Stephanie M. Baldwin, 609-359-3020
sbaldwin@antarespharma.com


'"/>




Page: 1 2 3

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment

Post Your Comments:
(Date:11/30/2009)..., , WALTHAM, Mass., Nov. 30 /PRNewswir..., the global authority on medical technology marke...ial injectable market declined by almost 5% over 2... as a result of the economic crisis. The market wi...will return to the strong pre-recession growth rat...
(Date:11/30/2009)..., , BOZEN, Italy, November 30 /PRNews... to unveil TPNstation,s development plans and prod...cept: "Totally Automated Parenteral,Nutrition", a ...ision to be,showcased at Las Vegas, ASHP (Booth # ...on from our customers to the,TPNstation,s blueprin...
(Date:11/30/2009)..., , ATLANTA, Nov. 30 Amoe...urgery breast care products, is sponsoring the 4th...or the first time, Amoena will honor survivors and... by awarding a cabin for the one with the most ins...test, Amoena wants to hear about young mothers who...
Breaking Medicine Technology:Facial Injectables Emerge From the Recession 2Facial Injectables Emerge From the Recession 3Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 3Amoena and Young Survival Coalition Celebrate Breast Cancer Survivors With Contest and Cruise 2Leading for Growth in the New Economic Reality Includes Vision and Innovation 12654 1Leading for Growth in the New Economic Reality Includes Vision and Innovation 12654 2Leading for Growth in the New Economic Reality Includes Vision and Innovation 12654 3Oral and Maxillofacial Surgeons Applaud Senator Mary Landrieu 28D LA 29 For Introducing Legislation to Require Insurance Coverage for Children With C 49078 1Oral and Maxillofacial Surgeons Applaud Senator Mary Landrieu 28D LA 29 For Introducing Legislation to Require Insurance Coverage for Children With C 49078 2Premiere Fibers Unveils New Logo Names for Innovative Brands 49074 1Premiere Fibers Unveils New Logo Names for Innovative Brands 49074 2
...iality pharmaceutical,company focused on the disco... to overcome the significant global problem of mic...dvanced injectable,antibacterial, which combines N...NXL104, with the well established cephalosporin an...l trials., The initial Phase II trial with NXL104...
...Acetaldehyde Levels in Subset of,Subjects with Inb...Nov. 11 Raptor,Pharmaceuticals Corp. ("Raptor" or...announced positive results in its Phase IIa study ... ALDH2 deficiency, or ethanol,intolerance, as the ...ram.,Convivia(TM) is Raptor,s proprietary oral for...
Other Medicine Technology:Novexel's NXL104/ceftazidime Combination Commences Phase II Clinical Trial in Hospital Patients With Complicated Urinary Tract Infections 2Novexel's NXL104/ceftazidime Combination Commences Phase II Clinical Trial in Hospital Patients With Complicated Urinary Tract Infections 3Novexel's NXL104/ceftazidime Combination Commences Phase II Clinical Trial in Hospital Patients With Complicated Urinary Tract Infections 4Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program 2Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program 3Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program 4Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program 5
(Date:11/30/2009)...PRNewswire/ -- High-frequency ultrasound with elas...and benign skin conditions, according to a study p...ogical Society of North America (RSNA). ,, "Hig...otential to improve the efficiency of skin cancer ..., vice chairman of the Department of Radiology at ...
(Date:11/30/2009)...PRNewswire/ -- A study presented today at the annu...erica (RSNA) revealed that MRI is a highly accurat...ally life-threatening and increasingly common cond... just before and after giving birth. ,, "Due t...eries that leave scarring on the uterine wall, cou...
(Date:11/30/2009)...ov. 30 VitaminSpice (OTC...ected William "Bill" R. Fields to the Board of Dir...airman of Intersource Co. Ltd. Mr. Fields is a Dir...r. Fields served as Chairman and Chief Executive O...03, President and Chief Executive Officer of Hudso...
(Date:11/30/2009)... Nov. 30 In Massachuset...sease are cared for at home, so the Alzheimer,s As... 24/7 Helpline during the holiday season. For most...for togetherness and sharing, but for a family dea...ful and filled with special challenges, according ...
(Date:11/30/2009)...istrator Alonzo L. Fulgham ,, WASHINGTON, Nov....e global community once again recognizes World AID...DS worldwide. This is also a time to renew our co...idemic and pay homage to the millions of people wh... partner in the U.S. President,s Emergency Plan fo...
Breaking Medicine News(10 mins):Health News:Special Ultrasound Accurately Identifies Skin Cancer 2Health News:Special Ultrasound Accurately Identifies Skin Cancer 3Health News:MRI Helps Detect Life-Threatening Pregnancy Complication 2Health News:MRI Helps Detect Life-Threatening Pregnancy Complication 3Health News:VitaminSpice Elects Bill Fields to the Board of Directors 2Health News:Alzheimer's Caregivers Face Holiday Stress 2Health News:USAID Recognizes World AIDS Day 2
...ce of birth determines the life expectancy with ba...life expectancy than those born in south east Engl...'s largest city was found to be 69.3 it was found ... born, based on life expectancy figures for 2002 t...
...has claimed that children who grow up in poverty o...health problems //. A recent report has reveal...unds or suffer from several mental health-related ...eightened risk. Dr Vivienne Nathanson, head of...
... has insisted that hospital consultants who are no...chase Fund (NTPF) //must be named voicing concerns...s from several hospitals that have long waiting li...dure. "There's no doubt there are some hospi...
...r William Ledger, a fertility expert at the Univer...producing //a baby through in-vitro fertilisation ...s lifetime. The study states that the benefits of ...economists used a modelling exercise and calculate...
...t Health Boards (DHBs), striking junior doctors re...// The doctor's union - Resident Doctors' A... contracts for about six hours on Monday and plann...ortunately last time talk was a failure and the RD...
..., elected to undergo hysterectomy and mastectomy. ... susceptibility her family harbors to develop brea...old that she would have wait for at least two more...ses from genetics watchdogs to perform the tests a...
Other Medicine News:Health News:Life Expectancy Determined by Place of Birth 2Health News:Free IVF Treatment Could Prove Beneficial to the Society And Its Economy 2Health News:Woman Elects For Mastectomy: Prolonged Wait For Genetic Results 2Health News:Woman Elects For Mastectomy: Prolonged Wait For Genetic Results 3
...s several different two-stage, oil-sealed, rotary ...rd freeze drying applications. Each pump comes com...d and Oil Mist Filter (EMF-10). The GBORK allows t...clean without losing oil. The EMF10 filter the exh...
QIAvac Multiwell
Variable Speed Pump 120 V
Vac-Man® Jr. Laboratory Vacuum Manifold, 2-sample capacity
Medicine Products: